DEAR VISITORS, THE NEW WEBSITE IS UNDER CONSTRUCTION, SO WE ASK FOR YOUR UNDERSTANDING IF YOU ENCOUNTER OUT-OF-DATE OR INCORRECT INFORMATION. FOR ALL QUESTIONS, WE ARE AT YOUR DISPOSAL BY PHONE +38131597597 or e-mail address: office@cigota.rs
DEAR VISITORS, THE NEW WEBSITE IS UNDER CONSTRUCTION, SO WE ASK FOR YOUR UNDERSTANDING IF YOU ENCOUNTER OUT-OF-DATE OR INCORRECT INFORMATION. FOR ALL QUESTIONS, WE ARE AT YOUR DISPOSAL BY PHONE +38131597597 or e-mail address: office@cigota.rs
Tim istraživača sa University of Massachusetts Medical School, Harvard University i nekoliko bostonskih univerzitetskih bolnica našao je da je receptor za angionetnzin konvertujući enzim 2 (ACE2) funkcijski receptor koji omogućava SARS virusu da inficira humane ćelije. Ovo otkriće identifikuje verovatni cilj za razvijanje farmakoloških supstanci ali i vakcine protiv virusa koji izaziva težak akutni respiratorni sindrom (SARS). Detalji ovog otkrića saopšteni su u novembarskom broju časopisa “Nature”.